PYC Therapeutics

ADOA PROGRAM – PRESENTATION AT NANOS 2026

PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available One of PYC’s clinical-stage programs is an investigational drug candidate (known as PYC-001) that targets the underlying cause of a blinding eye disease of childhood called Autosomal Dominant Optic Atrophy (ADOA) PYC today...
6 Verdun Street, Nedlands, Western Australia 6009

+61 8 6151 0992